Carbylan Therapeutics Company Profile (NASDAQ:CBYL)

About Carbylan Therapeutics

Carbylan Therapeutics logoCarbylan Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of combination therapies. The Company's focus is on the development of Hydros-TA, its intra-articular injectable product candidate to treat pain associated with osteoarthritis (OA) of the knee. The Hydros-TA is a cross-linked combination of low dose corticosteroid and hyaluronic acid viscosupplement, designed to provide OA pain relief through a single intra-articular injection. Its technology includes drug/device combination products under development based on chemically engineered polymer systems incorporating hyaluronic acid, a polysaccharide present in the human body. Hydros-TA utilizes crosslinking technology to deliver both short-term pain relief with a low dose corticosteroid triamcinolone acetonide (TA) and sustained pain relief from its hyaluronic acid viscosupplement. The Company has not generated any revenues.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBYL
  • CUSIP:
Key Metrics:
  • Previous Close: $0.50
  • 50 Day Moving Average: $0.564
  • 200 Day Moving Average: $0.707
  • 52-Week Range: $0.49 - $5.74
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.35
  • P/E Growth: 0.000
  • Market Cap: $12.96M
  • Outstanding Shares: 26,335,000
  • Beta: 2.78
Additional Links:
Companies Related to Carbylan Therapeutics:

Analyst Ratings

Consensus Ratings for Carbylan Therapeutics (NASDAQ:CBYL) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.95 (1,506.06% upside)

Analysts' Ratings History for Carbylan Therapeutics (NASDAQ:CBYL)
Show:
DateFirmActionRatingPrice TargetDetails
4/18/2016JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$9.00 -> $8.00View Rating Details
2/29/2016WedbushReiterated RatingOutperform$14.00View Rating Details
2/2/2016Leerink SwannDowngradeOutperform -> Market Perform$15.00 -> $1.80View Rating Details
6/9/2015Northland SecuritiesReiterated RatingOutperform$20.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Carbylan Therapeutics (NASDAQ:CBYL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2015        
11/11/2015Q315($0.26)($0.19)$0.01 millionViewListenView Earnings Details
8/11/2015Q215($0.21)($0.37)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Carbylan Therapeutics (NASDAQ:CBYL)
Current Year EPS Consensus Estimate: $-1.07 EPS
Next Year EPS Consensus Estimate: $-1.41 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.24)($0.23)($0.24)
Q2 20162($0.27)($0.25)($0.26)
Q3 20162($0.29)($0.28)($0.29)
Q4 20161($0.30)($0.30)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Carbylan Therapeutics (NASDAQ:CBYL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Carbylan Therapeutics (NASDAQ:CBYL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/30/2015David RenziCEOSell10,000$3.70$37,000.00View SEC Filing  
4/14/2015Acmp Iv LlcMajor ShareholderBuy877,500$5.00$4,387,500.00View SEC Filing  
4/14/2015Albert ChaDirectorBuy1,012,500$5.00$5,062,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Carbylan Therapeutics (NASDAQ:CBYL)
DateHeadline
capitalcube.com logoETF’s with exposure to Carbylan Therapeutics, Inc. : August 29, 2016 (NASDAQ:CBYL)
www.capitalcube.com - August 29 at 3:29 PM
News IconStock Gapping Lower Before the Bell: Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Post News (NASDAQ:CBYL)
www.kentuckypostnews.com - August 25 at 9:31 PM
investornewswire.com logoCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - August 25 at 4:08 PM
News IconAnalyst's keeping an Eye on: Carbylan Therapeutics, Inc. (NASDAQ:CBYL), Cabot Oil & Gas Corporation (NYSE:COG) - Newburg Press (NASDAQ:CBYL)
newburghpress.com - August 24 at 12:08 PM
News IconStocks Making Notable Moves: Zoetis Inc. (NYSE:ZTS), Carbylan Therapeutics (NASDAQ:CBYL) - Street Wise Report (press release) (blog) (NASDAQ:CBYL)
streetwisereport.com - August 24 at 12:08 PM
finance.yahoo.com logoCARBYLAN THERAPEUTICS, INC. Financials (NASDAQ:CBYL)
finance.yahoo.com - August 20 at 4:09 PM
News IconCrowd Sentiment & Wall Street Views on Carbylan Therapeutics, Inc. (NASDAQ:CBYL)? - Post News (NASDAQ:CBYL)
www.kentuckypostnews.com - August 17 at 4:13 PM
capitalcube.com logoETF’s with exposure to Carbylan Therapeutics, Inc. : August 17, 2016 (NASDAQ:CBYL)
www.capitalcube.com - August 17 at 4:13 PM
capitalcube.com logoCarbylan Therapeutics, Inc. :CBYL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:CBYL)
www.capitalcube.com - August 16 at 10:28 AM
biz.yahoo.com logoCARBYLAN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CBYL)
biz.yahoo.com - August 12 at 9:21 PM
streetupdates.com logoAnalysts Watch-list Stocks: Carbylan Therapeutics, Inc. (NASDAQ:CBYL) , DaVita healthCare Partners Inc. (NYSE:DVA) - Street Updates (NASDAQ:CBYL)
www.streetupdates.com - August 4 at 9:49 PM
biz.yahoo.com logoCARBYLAN THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or (NASDAQ:CBYL)
biz.yahoo.com - July 29 at 4:07 PM
investornewswire.com logoCan Shares Of Carbylan Therapeutics, Inc. (NASDAQ:CBYL) Hit $10? - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - July 28 at 12:52 PM
News IconCarbylan Therapeutics, Inc. (NASDAQ:CBYL): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - July 22 at 12:14 PM
News IconEquity Roundup: Stock Performance Focus on Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 21 at 9:39 PM
investornewswire.com logoIs $10 Price Target Attainable For Carbylan Therapeutics, Inc. (NASDAQ:CBYL)? - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - July 21 at 8:21 AM
News IconCarbylan Therapeutics Incorporated (NASDAQ:CBYL) Shorts Decreased by 59.61% After Short Covering - Consumer Eagle (NASDAQ:CBYL)
www.consumereagle.com - July 19 at 9:29 PM
News IconActive Moments in Stocks - Citigroup, (NYSE:C), Carbylan Therapeutics, (NASDAQ:CBYL) - Hot Stocks Point (NASDAQ:CBYL)
www.hotstockspoint.com - July 19 at 4:10 PM
News IconActive Movers - HSBC Holdings, (NYSE:HSBC), Carbylan Therapeutics, (NASDAQ:CBYL) - Hot Stocks Point (NASDAQ:CBYL)
www.hotstockspoint.com - July 18 at 9:07 AM
News IconCarbylan Therapeutics Incorporated (NASDAQ:CBYL) Sellers Increased By 1.49% Their Shorts - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 17 at 3:54 PM
News IconShares Moving Down on the Week: Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - July 17 at 3:54 PM
News IconAnalyst Target and Average Rating Watch: Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 15 at 1:29 PM
News IconCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - July 15 at 1:29 PM
News IconTrading Performance and Target Watch for Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 15 at 1:29 PM
News IconCarbylan Therapeutics Incorporated (NASDAQ:CBYL) Short Interest Increased By 1.49% - Consumer Eagle (NASDAQ:CBYL)
www.consumereagle.com - July 14 at 9:35 PM
investornewswire.com logoStrong Sell Calls For Carbylan Therapeutics, Inc. (NASDAQ:CBYL) At 0 - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - July 14 at 9:35 PM
News IconCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:CBYL)
telanaganapress.com - July 13 at 12:13 PM
News IconStock Rating Watch and Earnings Insight for Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 11 at 8:56 AM
fiscalstandard.com logoCarbylan Therapeutics, Inc. (CBYL) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CBYL)
www.fiscalstandard.com - July 10 at 3:59 PM
News IconCan Carbylan Therapeutics, Inc. (NASDAQ:CBYL) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - July 8 at 12:04 PM
News IconCompany Stock Focus for Carbylan Therapeutics, Inc. (NASDAQ:CBYL): Which Way Will Shares Head? - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 8 at 12:04 PM
ftsenews.co.uk logoNew Broker Ratings For Carbylan Therapeutics, Inc. (CBYL) - FTSE News (NASDAQ:CBYL)
www.ftsenews.co.uk - July 7 at 11:57 AM
investornewswire.com logoCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Expected to Reach Highs Of $10 - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - July 7 at 11:57 AM
News IconAre Analysts Bearish Carbylan Therapeutics Inc (NASDAQ:CBYL) After Last Week? - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - July 3 at 3:57 PM
News IconCovering the Bases on Carbylan Therapeutics, Inc. (NASDAQ:CBYL): Where is the Stock Going? - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - July 1 at 12:10 PM
News IconCarbylan Therapeutics Incorporated (NASDAQ:CBYL) Short Interest Increased By 1.49% - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - June 30 at 4:21 PM
News IconCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Company Rating and Target Watch - Telanagana Press (NASDAQ:CBYL)
telanaganapress.com - June 29 at 11:21 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Carbylan Therapeutics, Inc. (CBYL) - Fiscal Standard (NASDAQ:CBYL)
www.fiscalstandard.com - June 29 at 11:21 AM
biz.yahoo.com logoCARBYLAN THERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement (NASDAQ:CBYL)
biz.yahoo.com - June 28 at 4:13 PM
News IconPrice Target Highlight: Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - News Oracle (NASDAQ:CBYL)
www.newsoracle.com - June 28 at 3:26 PM
News IconShare Update and Earnings Review for Carbylan Therapeutics, Inc. (NASDAQ:CBYL) - Press Telegraph (NASDAQ:CBYL)
presstelegraph.com - June 27 at 8:43 AM
News IconCarbylan Therapeutics Incorporated (NASDAQ:CBYL) Shorted Shares Increased By 1.49% - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - June 26 at 9:14 AM
News IconCarbylan Therapeutics, Inc. (NASDAQ:CBYL) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:CBYL)
www.engelwooddaily.com - June 24 at 4:12 PM
tradecalls.org logoPrice Target Update on Carbylan Therapeutics (NASDAQ:CBYL) - Trade Calls (NASDAQ:CBYL)
www.tradecalls.org - June 24 at 4:12 PM
ftsenews.co.uk logoCarbylan Therapeutics, Inc. (CBYL) Updated Price Targets - FTSE News (NASDAQ:CBYL)
www.ftsenews.co.uk - June 24 at 11:55 AM
biz.yahoo.com logoCARBYLAN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi (NASDAQ:CBYL)
biz.yahoo.com - June 22 at 4:48 PM
investornewswire.com logoStrong Buy Calls Count For Carbylan Therapeutics, Inc. (NASDAQ:CBYL) At 2 - Investor Newswire (NASDAQ:CBYL)
www.investornewswire.com - June 22 at 4:12 PM
finance.yahoo.com logoCarbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction (NASDAQ:CBYL)
finance.yahoo.com - June 22 at 4:00 PM
fiscalstandard.com logoCarbylan Therapeutics, Inc. (CBYL) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CBYL)
www.fiscalstandard.com - June 19 at 3:58 PM
streetupdates.com logoStocks inside Analysts Spotlight: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Carbylan Therapeutics, Inc. (NASDAQ ... - Street Updates (NASDAQ:CBYL)
www.streetupdates.com - June 17 at 3:59 PM

Social

Carbylan Therapeutics (NASDAQ:CBYL) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff